(Q24670560)
Statements
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine (English)
0 references
March 2005
0 references
144
0 references
6
0 references
821-9
0 references
0 references
1 reference
1 reference
1 reference
1 reference